LON:AVO Advanced Oncotherapy - AVO Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Advanced Oncotherapy plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 9.75 0.00 (0.00%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's Range 9.50▼ 1050-Day Range 9.75▼ 17.1052-Week Range 9.50▼ 32Volume501,943 shsAverage Volume593,889 shsMarket Capitalization£52.40 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsInsider TradesHeadlines About Advanced Oncotherapy (LON:AVO) StockAdvanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.Read More Receive AVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter. Email Address AVO Stock News HeadlinesJanuary 27, 2023 | finanznachrichten.deHardman & Co Research: Q&A on Advanced Oncotherapy (AVO): Current EV significantly below cumulative investment to dateJanuary 3, 2023 | finance.yahoo.comIndependent Non-Executive Director Michael Bradfield Just Bought 6.4% More Shares In Advanced Oncotherapy plc (LON:AVO)February 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.December 13, 2022 | marketwatch.comAdvanced Oncotherapy Raises GBP1.5 Mln Via High-Premium Share SubscriptionOctober 27, 2022 | proactiveinvestors.comProactive news headlines: Deepverge, Greatland Gold, Seeing Machines, and moreSeptember 29, 2022 | uk.finance.yahoo.comHardman & Co Research on Advanced Oncotherapy: Major milestone achievedSeptember 8, 2022 | finance.yahoo.comAdvanced Oncotherapy plc (LON:AVO) has caught the attention of institutional investors who hold a sizeable 39% stakeAugust 1, 2022 | finance.yahoo.comIs Now An Opportune Moment To Examine Advanced Oncotherapy plc (LON:AVO)?February 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.July 2, 2022 | finance.yahoo.comCalculating The Intrinsic Value Of Advanced Oncotherapy plc (LON:AVO)March 31, 2022 | proactiveinvestors.comAdvanced Oncotherapy's technology can slash costs of proton therapy cancer treatment says CEOMarch 26, 2022 | proactiveinvestors.com.auProactive weekly mining highlights: Horizonte, Atlantic Lithium, East Star and moreMarch 25, 2022 | proactiveinvestors.comAdvanced Oncotherapy raises £2mln at a premiumMarch 1, 2022 | proactiveinvestors.comFTSE 100 in the red as fighting in Ukraine is intensifying with RussiaMarch 1, 2022 | proactiveinvestors.comAdvanced Oncotherapy hails significant progress with regulatory submission as it updates on its timelineFebruary 25, 2022 | finance.yahoo.comAdvanced Oncotherapy plc (AVO.L)December 13, 2021 | proactiveinvestors.comAdvanced Oncotherapy says it is making good progress, but confirms previously-flagged delayNovember 15, 2021 | markets.businessinsider.comHardman & Co Research: Advanced Oncotherapy (AVO): On the home straightOctober 2, 2021 | finance.yahoo.comIs Advanced Oncotherapy plc (LON:AVO) Popular Amongst Insiders?September 2, 2021 | proactiveinvestors.comAdvanced Oncotherapy - Result of GM, TVR and clarification re warrantsAugust 12, 2021 | markets.businessinsider.comAdvanced Oncotherapy : Result of AGMAugust 12, 2021 | finanznachrichten.deHardman & Co Research: Advanced Oncotherapy (AVO) Funded to completionAugust 11, 2021 | proactiveinvestors.comAdvanced Oncotherapy - Proposed subscription and issuance of sharesJune 30, 2021 | proactiveinvestors.comAdvanced Oncotherapy says 2021 to be important yearJune 3, 2021 | proactiveinvestors.comAdvanced Oncotherapy signs initial deal to provide LIGHT system treatment rooms for £75.5mlnMay 29, 2021 | markets.businessinsider.comAdvanced Oncotherapy : Total Voting RightsMarch 22, 2021 | proactiveinvestors.comAdvanced Oncotherapy present research potentially offering 'powerful weapon to resistant cancers'See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive AVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter. Email Address AVO Company Calendar Last Earnings6/29/2020Today2/05/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolLON:AVO CUSIPN/A CIKN/A Webwww.advancedoncotherapy.com Phone+44-20-36178728FaxN/AEmployees139Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio98.71 Current Ratio1.26 Quick Ratio0.13 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 0.29 per share Price / Cash Flow33.50 Book ValueGBX 13.60 per share Price / Book0.72Miscellaneous Outstanding Shares537,481,000Free FloatN/AMarket Cap£52.40 million OptionableNot Optionable BetaN/A Key ExecutivesDr. Michael Jeffrey Sinclair (Age 79)Exec. Chairman Comp: $434.42kMr. Nicolas SerandourCEO & Exec. DirectorProf. Stephen Myers OBE (Age 75)Exec. Director Comp: $397.72kMr. Ed LeeCOO & Pres of EuropeMr. Graham PugheSr. Vice-Pres of AccountingMs. Berengere Pons-ChabordSr. Vice-Pres of Corp. Fin.Dr. Manuel GallasDirector of Technical & EngineeringMr. David NavasVP of Investor and PRMs. Bridget BiggarDirector of HRMs. Donatella UngaroManaging Director of ADAMMore ExecutivesKey CompetitorsBelluscuraLON:BELLKromek GroupLON:KMKCreo Medical GroupLON:CREOInspiration Healthcare GroupLON:IHCIntelligent Ultrasound GroupLON:IUGView All CompetitorsInsiders & InstitutionsEnrico Cipro VanniBought 80,000 shares on 12/28/2022Total: £1.04 M ($13.00/share)Michael J SinclairBought 80,000 shares on 12/23/2022Total: £960,000.00 ($12.00/share)Enrico Cipro VanniBought 100,000 shares on 3/2/2022Total: £2.60 M ($26.00/share)View All Insider Transactions AVO Stock - Frequently Asked Questions How have AVO shares performed in 2023? Advanced Oncotherapy's stock was trading at GBX 13.50 at the beginning of the year. Since then, AVO shares have decreased by 27.8% and is now trading at GBX 9.75. View the best growth stocks for 2023 here. How were Advanced Oncotherapy's earnings last quarter? Advanced Oncotherapy plc (LON:AVO) released its earnings results on Monday, June, 29th. The company reported ($9.83) EPS for the quarter, missing analysts' consensus estimates of ($8.90) by $0.93. What other stocks do shareholders of Advanced Oncotherapy own? Based on aggregate information from My MarketBeat watchlists, some companies that other Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Avesoro Resources (ASO), Oxford Biomedica (OXB), BMR Group (BMR), GW Pharmaceuticals (GWPH), Lancashire (LRE), Sirius Minerals (SXX), Renishaw (RSW), Scancell (SCLP) and Tullow Oil (TLW). What is Advanced Oncotherapy's stock symbol? Advanced Oncotherapy trades on the London Stock Exchange (LON) under the ticker symbol "AVO." How do I buy shares of Advanced Oncotherapy? Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Advanced Oncotherapy's stock price today? One share of AVO stock can currently be purchased for approximately GBX 9.75. How much money does Advanced Oncotherapy make? Advanced Oncotherapy (LON:AVO) has a market capitalization of £52.40 million. How many employees does Advanced Oncotherapy have? The company employs 139 workers across the globe. How can I contact Advanced Oncotherapy? Advanced Oncotherapy's mailing address is Third Fl Clearwater HSE, 4-7 Manchester Street, LONDON, W1U 3AE, United Kingdom. The official website for the company is www.advancedoncotherapy.com. The company can be reached via phone at +44-20-36178728. This page (LON:AVO) was last updated on 2/5/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.